CLNN: Clene Inc. Stock

by  •  • Comments Off on CLNN: Clene Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 36.63
Enterprise Value ($M) 39.80
Book Value ($M) -4.12
Book Value / Share -0.50
Price / Book -8.88
NCAV ($M) -16.00
NCAV / Share -1.92
Price / NCAV -2.29

Profitability (mra)
Return on Invested Capital (ROIC) -1.92
Return on Assets (ROA) -0.69
Return on Equity (ROE) -2.69

Liquidity (mrq)
Quick Ratio 0.82
Current Ratio 0.83

Balance Sheet (mrq) ($M)
Current Assets 19.70
Assets 31.57
Liabilities 35.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -40.13
02-14 13G/A AWM Investment Company, Inc. 5.70 -96.06
02-12 13G/A Mosca Alison 19.70 94.89
2024-02-14 13G/A Citadel Advisors Llc 4.50
2024-02-13 13G/A Vivo Opportunity Fund Holdings, L.P. 7.00 -29.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-13 7,771 30,466 25.51
2025-03-12 4,852 81,167 5.98
2025-03-11 2,171 39,037 5.56
2025-03-10 7,940 35,597 22.31

(click for more detail)

Similar Companies
CING – Cingulate Inc. CKPT – Checkpoint Therapeutics, Inc.
CLDX – Celldex Therapeutics, Inc. CLRB – Cellectar Biosciences, Inc.
CMPX – Compass Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io